| KAMAR, Nassim |
EASY, NCT06354179: Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation |
|
|
| Not yet recruiting | 4 | 162 | Europe | XR-tacrolimus QD + MMF BID then MMF QD, XR-tacrolimus QD + MMF BID, LCP-tacrolimus QD + MMF QD then MMF QD, LCP-tacrolimus QD + MMF BID | University Hospital, Limoges | Liver Transplantation, Immunosuppression | 02/28 | 02/28 | | |
| Recruiting | 3 | 272 | Europe | 56 days of weight-adjusted L-Carnitine treatment, 10 days of intravenous placebo (isotonic saline) | Centre Hospitalier Universitaire de Nīmes | Severe Sepsis, Shock, Septic, Acute Kidney Injury | 05/25 | 05/26 | | |
| Active, not recruiting | 3 | 346 | Europe | Corticosteroid boluses Methylprednisolone, No therapeutic modification, Stop maintenance corticotherapy | Hospices Civils de Lyon | Renal Transplantation | 12/24 | 12/24 | | |
| Active, not recruiting | 3 | 50 | Europe, US, RoW | Imlifidase, IdeS, HMED-IdeS, Plasma exchange (PLEX), PE, Cyclophosphamide (CYC), Glucocorticoids | Hansa Biopharma AB | Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease, Goodpasture Syndrome, Good Pasture Syndrome | 06/25 | 11/26 | | |
SHORTCUT, NCT05597540 / 2022-002319-43: Efficacy of 7 Days Versus 14 Days of Antibiotic Therapy for Acute Pyelonephritis in Kidney Transplant Recipients, a Multicentre Randomized Non-inferiority Trial. |
|
|
| Recruiting | 3 | 470 | Europe | Short antibiotic treatment, Usual antibiotic treatment | Assistance Publique - Hôpitaux de Paris, DGOS | Pyelonephritis Acute, Kidney Transplant Infection | 03/27 | 08/27 | | |
| Terminated | 3 | 194 | Europe, Canada, US, RoW | Clazakizumab, Physiologic saline solution | CSL Behring, ICON Clinical Research | Antibody-mediated Rejection | 04/24 | 04/24 | | |
VARVARA, NCT05907096: ARGX-117 in Deceased Donor Kidney Transplant Recipients At Risk for Delayed Graft Function |
|
|
| Recruiting | 2 | 102 | Europe, Canada, US, RoW | ARGX-117, Placebo | argenx | Delayed Graft Function | 04/26 | 12/26 | | |
| Completed | N/A | 490 | Europe | Kidney transplant | University Hospital, Brest | End Stage Renal Diseases | 07/22 | 09/23 | | |
AI-CARE, NCT06406179: Assesment the Efficacy of Dd-cfDNA in Routine Patient Care in Kidney Transplant Recipients" |
|
|
| Not yet recruiting | N/A | 500 | Europe | dd-cfDNA-guided | Assistance Publique - Hôpitaux de Paris | Renal Transplantation | 06/27 | 06/27 | | |
| Recruiting | N/A | 150 | Europe, RoW | No Intervention | Takeda | Cytomegalovirus (CMV) | 04/25 | 04/25 | | |
| Recruiting | N/A | 720 | Europe | Post-transplant addiction intervention | University Hospital, Montpellier | Alcohol Associated Liver Disease, Liver Transplantation | 09/26 | 09/28 | | |
HORUS, NCT05701228: Casting Light on HOst-cytomegaloviRUs Interaction in Solid Organ Transplantation |
|
|
| Recruiting | N/A | 525 | Europe | | University Hospital, Bordeaux, European Commission | Cytomegalovirus Infections, Solid Organ Transplantation | 06/26 | 06/26 | | |
| Juliette, MAZEREEUW-HAUTIER |
| Recruiting | 2 | 55 | Europe | Topical 0.1% Sirolimus, Verum, Topical Vehicle, Placebo | University Hospital, Tours, University Hospital, Angers | Vascular Malformations, Lymphatic Malformation | 09/23 | 06/24 | | |
| Not yet recruiting | 2 | 26 | NA | Gentamicin Injectable Solution | University Hospital, Toulouse | Ichthyosis | 04/26 | 04/27 | | |
